Shares of Cerner (NASDAQ:CERN) rose 1.38% in after-market trading after the company reported Q2 results.
Earnings per share fell 4.55% over the past year to $0.63, which beat the estimate of $0.61.
Revenue of $1,330,000,000 declined by 7.06% from the same period last year, which missed the estimate of $1,360,000,000.
The upcoming fiscal year's EPS expected to be between $2.80 and $2.88.
The upcoming fiscal year's revenue expected to be between $5,450,000,000 and $5,550,000,000.
Details Of The Call
Date: Jul 29, 2020
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/i4w8bruc
Company's 52-week high was at $80.90
52-week low: $53.08
Price action over last quarter: Up 3.38%
Cerner is a leading supplier of health care information technology solutions and tech-enabled services. The company offers a wide range of intelligent solutions and tech-enabled services that support the clinical, financial, and operational needs of healthcare organizations of varying sizes. The company employs nearly 30,000 associates and has a strong global installed base, including the lion's share of the top 100 health systems, physician practices, laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics, surgery centers, extended care facilities, retail pharmacies, and employer sites. The company is guided by the mission of the founding partners to provide seamless medical records across all healthcare providers to improve outcomes.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.